Skip to content

Clinical trials

Completed Adenocarcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20081
20102
20111
20142
20152
20163
20171
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Abbott1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Ariad Pharmaceuticals1
Celgene1
Clovis Oncology, Inc.1
Erasmus Medical Center1
European Organisation for Research and Treatment of Cancer - EORTC1
Genzyme, a Sanofi Company1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma18
Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Carcinoma4
Carcinoma, Squamous Cell4
Neoplasms by Site4
Carcinoma, Renal Cell3
Digestive System Diseases3
Digestive System Neoplasms3
Endocrine Gland Neoplasms3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.